Jane Stevens

971 total citations
12 papers, 620 citations indexed

About

Jane Stevens is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Jane Stevens has authored 12 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Jane Stevens's work include Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Jane Stevens is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Jane Stevens collaborates with scholars based in United Kingdom, United States and Greece. Jane Stevens's co-authors include Jude Fitzgibbon, Tim Lister, Donna L. Forrest, Clayton A. Smith, Shannon Jackson, Brian Leber, Peter Johnson, Cynthia L. Toze, Carolyn Owen and Man‐Chiu Poon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Jane Stevens

12 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Stevens United Kingdom 8 390 221 160 157 82 12 620
Katarina Reinhardt Germany 13 318 0.8× 211 1.0× 107 0.7× 80 0.5× 47 0.6× 20 551
Marie Jarošová Czechia 17 354 0.9× 264 1.2× 108 0.7× 301 1.9× 58 0.7× 87 766
Inés Gómez‐Seguí Spain 11 253 0.6× 178 0.8× 219 1.4× 93 0.6× 29 0.4× 60 603
JR Downing United States 9 534 1.4× 331 1.5× 434 2.7× 78 0.5× 56 0.7× 9 823
Sandrine Geffroy France 14 578 1.5× 393 1.8× 97 0.6× 419 2.7× 54 0.7× 32 949
RP Castleberry United States 8 235 0.6× 195 0.9× 73 0.5× 143 0.9× 36 0.4× 9 469
R. Haas Germany 13 358 0.9× 173 0.8× 175 1.1× 106 0.7× 49 0.6× 48 820
ER van Wering Netherlands 12 719 1.8× 317 1.4× 649 4.1× 215 1.4× 62 0.8× 16 1.1k
P Buchinger Austria 13 411 1.1× 124 0.6× 127 0.8× 81 0.5× 51 0.6× 22 632
G.H. Borgström Finland 16 587 1.5× 174 0.8× 348 2.2× 284 1.8× 137 1.7× 24 919

Countries citing papers authored by Jane Stevens

Since Specialization
Citations

This map shows the geographic impact of Jane Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Stevens more than expected).

Fields of papers citing papers by Jane Stevens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Stevens. The network helps show where Jane Stevens may publish in the future.

Co-authorship network of co-authors of Jane Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Stevens. A scholar is included among the top collaborators of Jane Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Stevens. Jane Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Breen, David P., et al.. (2017). Soft tissue plasmacytomas in multiple myeloma. The Lancet. 390(10107). 2083–2083. 6 indexed citations
2.
Stevens, Jane, Rachel Waters, Shireen Kassam, et al.. (2011). Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies. British Journal of Haematology. 154(4). 448–456. 17 indexed citations
3.
Agarwal, Neeraj, et al.. (2010). Plasma cell myeloma diagnosed in pregnancy. BMJ Case Reports. 2010. bcr0420102901–bcr0420102901. 4 indexed citations
4.
Stevens, Jane, et al.. (2009). Patterns of recruitment into acute myeloid leukaemia (AML) 15 and outcome for young patients with AML at a single referral centre. British Journal of Haematology. 145(1). 40–44. 6 indexed citations
5.
Owen, Carolyn, Cynthia L. Toze, Donna L. Forrest, et al.. (2008). Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood. 112(12). 4639–4645. 168 indexed citations
6.
7.
Paulsson, Kajsa, Jean‐Baptiste Cazier, Finlay MacDougall, et al.. (2008). Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease. Proceedings of the National Academy of Sciences. 105(18). 6708–6713. 77 indexed citations
8.
Gale, Rosemary E., Robert K. Hills, Ιoannis Kakkas, et al.. (2007). Mutation of the Wilms’ Tumor 1 Gene Is a Poor Prognostic Factor Associated with Chemoresistance in Normal Karyotype Acute Myeloid Leukemia.. Blood. 110(11). 361–361. 7 indexed citations
9.
Walker, Logan C., Jane Stevens, Hamish G. Campbell, et al.. (2002). A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia. British Journal of Haematology. 117(4). 878–881. 43 indexed citations
10.
11.
Gallus, Alexander, J. F. Cade, Paul Ockelford, et al.. (1993). Orgaran (Org 10172) or Heparin for Preventing Venous Thrombosis after Elective Surgery for Malignant Disease? A Double-Blind, Randomised, Multicentre Comparison. Thrombosis and Haemostasis. 70(4). 562–567. 45 indexed citations
12.
Viskochil, David, et al.. (1991). The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene.. Molecular and Cellular Biology. 11(2). 906–912. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarina Reinhardt Breakdown of academic impact, for papers by Marie Jarošová Breakdown of academic impact, for papers by Inés Gómez‐Seguí Breakdown of academic impact, for papers by JR Downing Breakdown of academic impact, for papers by Sandrine Geffroy Breakdown of academic impact, for papers by RP Castleberry Breakdown of academic impact, for papers by R. Haas Breakdown of academic impact, for papers by ER van Wering Breakdown of academic impact, for papers by P Buchinger Breakdown of academic impact, for papers by G.H. Borgström
Rankless by CCL
2026